Immunogenicity Assay Cut-Point Drift Across a Multi-Year Programme: A Short Communication. Translational Medicine & Therapeutics Journal, [S. l.], v. 4, n. 2, p. 83–91, 2025. DOI: 10.5281/zenodo.22649429. Disponível em: https://inkwise.org/index.php/TMTJ/article/view/112. Acesso em: 5 nov. 2026.